A Clinical Study in Male Pediatric Patients With Cerebral X-linked Adrenoleukodystrophy (Cald) to Assess the Effects of MIN-102 Treatment on Disease Progression Prior to Human Stem Cell Transplant (HSCT)

Summary

An Open-Label, multicenter study in male pediatric patients with cerebral x-linked adrenoleukodystrophy (cald) to assess the effects of MIN-102 treatment on disease progression prior to human stem cell transplant (HSCT)

Timeline

Start

2019-09-13

Primary completion

2023-12-31

Completion

2023-12-31

Outcome

Met primary endpoint

release “today announced that the NEXUS trial has been completed and that the primary endpoint has been met.” minoryx.com ↗

Drugs

Indications